CHI3L1 and Alzheimer disease: The trend of elevated CSF levels of YKL-40 in AD patients compared to healthy controls was significant (SMD = 0.893, 95%CI: [0.665, 1.121]; p = 0.000; I2 = 72.2%, p = 0.000; Figure 3).